Early treatment with sumatriptan prevents PACAP38-induced migraine: A randomised clinical trial

Objective To determine whether early treatment with sumatriptan can prevent PACAP38-induced migraine attacks. Methods A total of 37 patients with migraine without aura were enrolled between July 2018 to December 2019. All patients received an intravenous infusion of 10 picomole/kg/min of PACAP38 ove...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Cephalalgia 2021-05, Vol.41 (6), p.731-748
Hauptverfasser:	Wienholtz, Nita Katarina Frifelt, Christensen, Casper Emil, Zhang, Ditte Georgina, Coskun, Hande, Ghanizada, Hashmat, Al-Karagholi, Mohammad Al-Mahdi, Hannibal, Jens, Egeberg, Alexander, Thyssen, Jacob P, Ashina, Messoud
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Adult Clinical Neurology Cross-Over Studies Double-Blind Method Humans Incidence Life Sciences & Biomedicine Middle Aged Migraine Disorders - chemically induced Migraine Disorders - epidemiology Migraine without Aura - epidemiology Migraine without Aura - prevention & control Neurosciences Neurosciences & Neurology Pituitary Adenylate Cyclase-Activating Polypeptide - adverse effects Science & Technology Sumatriptan - therapeutic use
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!